(PubMed) Nurk E, Refsum H, Bjelland I, et al
6, 15581562 doi: 10.1021/acsinfecdis.0c00288 54 Pujos-GuillotE.PickeringG.LyanB.DucheixG.Brandolini-BunlonM.GlomotF.et al
What side effects might I experience when combining these medications
+ Retatrutide is a triple-receptor agonist (GLP-1, GIP, and glucagon), whereas tirzepatide is dual-pathway (GLP-1 + GIP) and semaglutide is single-pathway (GLP-1 only)
In contrast, stimulant-based medications like phentermine cause increased energy and jitteriness rather than fatigue but come with different side effects
But remember what these are: early, mostly condition-specific results in people who already have obesity